SCHEMBL7983845

SCHEMBL7983845

COC(=O)c1c(C)nc2c(c1-c1ccc(Cl)cc1)C(=O)OC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
ALDH1A1 P00352 2/20 0.48
PLA2G2A P14555 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.42
TP53 P04637 2/20 0.42
MDM2 Q00987 1/20 0.42
KDM4E B2RXH2 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 2/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7978016 0.83 PLA2G2A (0.47) LMNAALDH1A1PLA2G2ASMN1; SMN2NPC1
SCHEMBL11015788 0.82 SMN1; SMN2 (0.44) LMNAALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL7984066 0.80 POLB (0.44) LMNAALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL8801276 0.80 KMT2A (0.41) LMNAALDH1A1SMN1; SMN2NPC1MAPT
SCHEMBL30209788 0.79 KDM4E (0.61) LMNAALDH1A1PLA2G2ASMN1; SMN2NPC1
SCHEMBL7979237 0.79 LMNA (0.53) LMNAALDH1A1PLA2G2ASMN1; SMN2NPC1
SCHEMBL8803269 0.79 LMNA (0.39) LMNAALDH1A1PLA2G2ASMN1; SMN2NPC1
SCHEMBL11009673 0.78 ALDH1A1 (0.55) LMNAALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL7979351 0.77 LMNA (0.80) LMNAALDH1A1PLA2G2ASMN1; SMN2NPC1
SCHEMBL7977550 0.76 NR3C2 (0.39) PLA2G2ASMN1; SMN2NPC1RAB9AABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194428-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2001-02-27 US disclosed